Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder

Clinical Cancer Research

Volumn 7, Issue 7, 2001, Pages 1957-1962

  Chow, N H ^a   Chan, S H ^a   Tzai, T S ^a   Ho, C L ^a   Liu, H S ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; TYROSINE KINASE RECEPTOR;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; STATISTICS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0034782994     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Growth factors: Regulation of normal and neoplastic growth
2. Expression patterns of ErbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study
3. Epidermal growth factor in human urine from birth to puberty
4. Comparison of urinary transforming growth factor-α in women with disseminated breast cancer and healthy control women
5. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors
6. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
7. Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
8. The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells
9. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas
10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors
11. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product
12. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner
13. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer
14. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: An immunohistochemical study
15. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas
16. Expression of c-erbB3 protein in primary breast carcinomas
17. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2
18. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix
19. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
20. The epidermal growth factor receptor and the prognosis of bladder cancer
21. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder
22. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis
23. Long-term outcome related to epidermal growth factor receptor status in bladder cancer
24. Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2
25. Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer
26. Epidermal growth factor receptor expression: Predictive value for the outcome after cystectomy for bladder cancer?
27. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: A prospective comparative study
28. Expression of transforming growth factor-α and epidermal growth factor receptor in human bladder cancer
29. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma
30. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer
31. C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer
32. Evaluation of epidermal growth factor receptor, transforming growth factor-α, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer
33. erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
34. In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity
35. A scoring system for immunohistochemical staining: Consensus report of the task force for basic research of the EORTC-GCCG
36. The ErbB signaling network: Receptor heterodimerization in development and cancer
37. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness
38. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
39. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
40. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
41. Association of c-erbB-2 protein overexpression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer
42. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: Receptor overexpression does not determine growth dependency
43. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder
44. Immune responses to all ErbB family receptors detectable in serum of cancer patients